Abstract:Background:Exosomal microRNAs (miRNAs) have been linked to the genesis and progression of certain cancers. The role and regulation mechanism of cancer-derived exosomal miRNAs in CRC, however, remain unknown.Methods:To address this, we first used miRNA sequencing to describe the miRNA profiles of circulating exosomes in order to identify miRNAs that were differently expressed between patients with CRC and healthy controls. Transmission electron microscopy, nanoparticle tracking analysis (NTA), and western blot were used to analyze exosomes generated from CRC cells. CCK-8, wound healing, and Transwell tests were used to see whether exosomes affected CRC cell proliferation, metastasis, and apoptosis, respectively. We chose and identified hsa-miR-3937, which was abundant in tumor-generated exosomes, based on earlier RNA sequencing data of exosomes obtained and extracted from seven matched specimens of tumor tissues and surrounding normal tissues of CRC patients.Results:The role of hsa-miR-3937 in CRC cells was found, and silencing of hsa-miR-3937 decreased CRC cell invasion and migration in a Transwell experiment. Furthermore, we discovered that there was no link between hsa-miR-3937 expression and CRC cell apoptosis. Initially, it was discovered that BCL2L12 was the target gene of hsa-miR-3937, and the TCGA database highlighted the potential therapeutic relevance of BCL2L12. Furthermore, to identify hsa-miR-3937 as a biomarker of CRC, we used peripheral blood samples rather than patient tissues and extracted exosomes from plasma samples. To assess the expression levels and predictive usefulness of plasma exosomal hsa-miR-3937 in CRC, we performed RT-qPCR to identify hsa-miR-3937 levels in all samples. We also gathered clinicopathological information in order to look for links between aberrant hsa-miR-3937 expression and clinicopathological characteristics. The pathologic stage of CRC patients was linked to hsa-miR-3937 expression levels, and the same was true for the T stage. ROC curve study revealed that hsa-miR-3937 outperforms CEA and CA199. The combination of hsa-miR-3937, CEA, and CA199 exhibited the highest sensitivity for CRC diagnosis.Conclusions:Our findings show that the tumor-originated exosomal hsa-miR-3937 is a potential and effective liquid biopsy marker for colorectal cancer detection and therapy.

Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer

Diagnostic Potential Of Serum Exosomal Colorectal Neoplasia Differentially Expressed Long Non-Coding Rna (Crnde-P) And Microrna-217 Expression In Colorectal Carcinoma

Circulating Exosomal Mir-150-5p and Mir-99B-5p As Diagnostic Biomarkers for Colorectal Cancer

Exosome-Encapsulated Micrornas As Circulating Biomarkers For Colorectal Cancer

The Potential of Exosomes Derived from Colorectal Cancer As a Biomarker

Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer

Exosomal miR‐1470 is a diagnostic biomarker and promotes cell proliferation and metastasis in colorectal cancer

Clinical Utility of Exosomal Micrornas for Colorectal Cancer

Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer.

Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression

Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer

Serum Exosomal Mir-377-3p and Mir-381-3p As Diagnostic Biomarkers in Colorectal Cancer

Identification of CD147-positive extracellular vesicles as novel non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer

Single-Exosome Profiling Identifies ITGB3+ and ITGAM+ Exosome Subpopulations as Promising Early Diagnostic Biomarkers and Therapeutic Targets for Colorectal Cancer

Tumor-Originated Exosomal Hsa-Mir-3937 As a Minimally Invasive Early Biomarker for Liquid Biopsy of Colorectal Cancer.

Serum Exosomal Mir-122 As a Potential Diagnostic and Prognostic Biomarker of Colorectal Cancer with Liver Metastasis

Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the Cerna Network.

Global and Targeted Circulating Microrna Profiling of Colorectal Adenoma and Colorectal Cancer.

Potential diagnostic role of circulating MiRNAs in colorectal cancer

Exosomes as potential sources of biomarkers in colorectal cancer

Association of Co-Occuring Mutations in Exosomal DNA and Clinical Outcomes of Patients with Metastatic Colorectal Cancer.